InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Jonathan Violin, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 10 open-market SEC Form 4 transactions: 0 purchases worth $0 and 10 sales worth $4.3M, reported from Feb 1, 22 to Feb 2, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 2, 23 | VRDNViridian Therapeutics, Inc.\DE | SELL | 50.0K | $36.80 | $1.8M |
| Jun 1, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 30.0K | $12.20 | $366K |
| May 2, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 30.0K | $13.04 | $391K |
| Apr 4, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 3.6K | $18.93 | $68K |
| Apr 1, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 26.4K | $18.92 | $499K |
| Mar 2, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 11.1K | $17.36 | $193K |
| Mar 1, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 18.9K | $17.82 | $337K |
| Feb 3, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 909 | $19.16 | $17K |
| Feb 2, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 12.3K | $18.47 | $228K |
| Feb 1, 22 | VRDNViridian Therapeutics, Inc.\DE | SELL | 16.8K | $19.55 | $327K |